Galapagos NV
GLPG
#4540
Rank
HK$17.44 B
Marketcap
HK$264.69
Share price
-0.73%
Change (1 day)
47.64%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -HK$2.52

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -HK$2.65. In 2024 the company made an earnings per share (EPS) of HK$9.11 a decrease over its 2023 EPS that were of HK$27.72.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$2.52-127.68%
2024HK$9.11-67.16%
2023HK$27.72-199.64%
2022-HK$27.8299.03%
2021-HK$13.98-68.98%
2020-HK$45.07-298.06%
2019HK$22.76-554.64%
2018-HK$5.01-77.18%
2017-HK$21.94-326.21%
2016HK$9.70-134.19%
2015-HK$28.36-371.34%
2014HK$10.45-445.98%
2013-HK$3.0232.88%
2012-HK$2.27-82.07%
2011-HK$12.68-817.9%
2010HK$1.7712.73%
2009HK$1.57-120.79%
2008-HK$7.54-37.67%
2007-HK$12.0939.64%
2006-HK$8.6628.17%
2005-HK$6.766.25%
2004-HK$6.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$81.56-3,178.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$62.95-2,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$10.56-498.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$28.95-1,192.75%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$59.33-2,339.29%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$23.71-994.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$28.09-1,160.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-HK$4.77 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$4.92-285.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel